Background: The effective management and development of new treatments for children with difficult asthma requires investigation of the underlying airway pathology and its relationships with persistent symptoms and airflow limitation. Methods: The density of immunologically distinct inflammatory cells and cells expressing interleukin (IL)-4, 11-5, and RANTES was determined in paraffin-embedded endobronchial biopsy specimens from 27 children with difficult asthma (6-16 years) following treatment with systemic corticosteroids. Eleven non- asthmatic children (7-16 years) acted as controls. Reticular basement membrane (RBM) thickness was also recorded and forced expiratory volume in 1 second (FEV1) and exhaled nitric oxide (FENO) measured, the latter in asthmatic children only. Results: RBM thickness was greater in the asthmatic than the control group (median (range) 7.4(3.1-1 1.1) v 5.1 (3.5-7.5) Î¼m, p =0.02). No other significant tissue difference was seen, nor was there a difference between asthmatic subjects with daily symptoms after systemic corticosteroids and those who became asymptomatic. CD4+ T lymphocyte density was higher in asthmatic subjects with persistent airflow limitation (post-bronchodilator FEV1 <80% predicted) than in those without (9.1 (5.5-13.6) v 3.5 (0.6- 34.9)%, p =0.027). Analysing all asthmatic subjects together, there were negative correlations between CD4+ I lymphocytes and both pre-bronchodilator FEV1 (r = -0.57(95% CI -0.79 to -0.23), p =0.002) and post-bronchodilator FEV1 (r = -0.61 (95% CI -0.81 to -0.29), p<0.001). There were no significant correlations between FENO and inflammatory cells of any type. Conclusion: In children with difficult asthma treated with systemic corticosteroids, persistent airflow limitation is associated with a greater density of CD4+ T lymphocytes in endobronchial biopsy specimens.

ACCESSION #

14882956

Related Articles

Background: Nitric oxide in exhaled air (FENO) is a marker of eosinophilic airway inflammation. A study was undertaken to determine whether FENO predicts asthma relapse in asymptomatic asthmatic children in whom inhaled corticosteroids are discontinued. Methods: Forty children (21 boys) of mean...

Corticosteroids are the foundation of pharmacologic treatment for children with asthma. However, high-dose inhaled corticosteroid treatment can cause hypothalamic-pituitary-adrenal (HPA) axis suppression. We investigated the effect of three doses of mometasone furoate administered via dry-powder...

Presents information on a study by R.J. Scarfone and others that studied the early administration of magnesium to moderately to severely ill children with asthma in a randomized, double-blind, placebo-controlled clinical trial. Description of the study and its results; Conclusion that among a...

Asthma is a chronic respiratory condition affecting many adults and children. An association between asthma and raised gaseous nitric oxide in the exhaled breath was first reported in 1993. In the absence of an objective test for diagnosing and monitoring asthma, a vigorous research effort has...

Introduction and Objectives Alveolar nitric oxide or (CANO), has been used as a surrogate marker of distal airway inflammation, which is important in COPD. Coarse particle inhaled corticosteroids (ICS) have been shown not to suppress CANO. We evaluated whether extra-fine particle size inhaled...

The article reports on a study to determine whether optimizing the inhaled corticosteroid dose using the fraction of nitric oxide in exhaled air can reduce asthma exacerbations and the daily dosage compared to the use of standard criteria for patients with chronic asthma. Patients aged 12-75...

The article comments on a study by A. D. Smith and colleagues to determine whether optimizing the inhaled corticosteroid dose using the fraction of nitric oxide in exhaled air can reduce asthma exacerbations and the daily dosage compared to the use of standard criteria for patients with chronic...